Funding & Deals

Boltz raises $110M for AI drug discovery models

SiliconANGLE: Medical AI startup Boltz raises $110M to speed up small molecule research

Boltz PBC, a startup that develops artificial intelligence models for pharmaceutical researchers, has raised $110 million in funding. Bessemer led the Series A investment. Boltz stated on Wednesday that the fund was joined by a large group of new and returning backers. The consortium included Greycroft, Andreessen Horowitz, Amplify Partners, F-Prime Capital, Hummingbird and others. […] The post Medical AI startup Boltz raises $110M to speed up small molecule research appeared first on Sili

Get smart on it

A medical AI startup has raised funding to develop artificial intelligence models that speed up pharmaceutical drug discovery. The startup's models reduce the number of candidate molecules researchers need to evaluate from hundreds of thousands down to dozens, cutting months of work and millions in costs from the drug discovery process. The models also generate protein designs based on molecular findings and evaluate their potential for drug development. Six of the world's largest pharmaceutical companies currently use these algorithms, and customer usage has grown significantly since the models launched earlier this year.

Read next
The biggest AI stories, once a day

One short email a day with the stories that matter. Free. Unsubscribe with one click.

Relevant courses

Want to go deeper than the news? Explore live, cohort-based AI courses taught by practitioners.

Browse AI courses on Maven
Related news
Funding & DealsOpen story →

Anthropic reportedly prices IPO at $83 a share, above projected range

The long-awaited IPO reportedly values the company at $1.5 trillion on a fully diluted basis.

Also reported by Crunchbase News, SiliconANGLE, Wired AI and The Verge

Funding & DealsOpen story →

Anthropic starts trading on Wall Street

Anthropic CEO Dario Amodei speaks at the Nasdaq ahead of his company’s public debut. | Photo by Michael Nagle/Bloomberg via Getty Images Anthropic has officially gone public. It began trading on the Nasdaq under the ticker symbol "ANT" at $111.50 per share, up from its initial $83 per share price that put company's value at around $1.5 trillion. The listing comes nearly a month after Anthropic revealed its plans to go public. In its lengthy S-1 filing, the AI company reported re

Funding & DealsOpen story →

Amazon and Google will together own nearly 30% of Anthropic after its IPO

Amazon will own just under 15% of Anthropic after the IPO, with the option to go much higher. Google is a close second with holdings of nearly 14%.

Also reported by Crunchbase News

Funding & DealsOpen story →

Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.

Also reported by SiliconANGLE

Funding & DealsOpen story →

Genesis AI Raises $500M At $3.5B Valuation To Bring Its Robots To Factories And Warehouses

Genesis AI, a startup teaching robots to perform physical tasks by learning from human movements, announced Tuesday it has raised $500 million in Series A funding at a $3.5 billion valuation. Premji Invest, Khosla Ventures and Eclipse co-led the round, which brings the company’s disclosed funding to $605 million since its 2024 inception. Genesis previously raised $105 million in a round announced in July 2025. The company is developing both robots and the AI software that controls them. Its appr

Funding & DealsOpen story →

Agile Robots raises $500M to increase production capacity

Agile Robots’ Agile ONE humanoid moving between workstations. | Source: Agile Robots Agile Robots has raised $500 million in Series F funding. This brings the company’s valuation to $8.5 billion and total funding raised to $2 billion. Agile Robots builds and deploys a range of robots, including humanoids, mobile robots, robotic arms, and robotic hands. It also builds the software and AI models behind these robots. The company’s customers include leaders in the automotive, consu